Start Date
5-28-2020 9:00 AM
End Date
5-28-2020 5:00 PM
Description
COVID-19 is a predominantly respiratory disease and Philadelphia is a city with a myriad of pulmonary comorbidities such as asthma and COPD.
Use of bronchodilator medications through a nebulizer machine is considered an 'Aerosol Generating Procedure' (AGP), and increases risks to staff who and complicates the cleaning and processing of rooms and equipment where AGPs are performed. Additionally, there is a severe limitation in availability of negative pressure rooms, which mitigate these AGPs.
With the COVID pandemic causing supply chain problems across the country, a multidisciplinary approach was required to appropriately ration available inhalers (MDI), the alternatives to nebulized treatments, while still treating patients who arrive with the need for these medications while maintaining maximal safety to staff.
Keywords
COVID-19, SARS-CoV-2, coronavirus, Emergency Medicine, Surge Space, Opioid Use Disorders, Bronchodilators
Included in
Progression of Patient Cohorting in Response to COVID-19 at the Jefferson Methodist Emergency Department
COVID-19 is a predominantly respiratory disease and Philadelphia is a city with a myriad of pulmonary comorbidities such as asthma and COPD.
Use of bronchodilator medications through a nebulizer machine is considered an 'Aerosol Generating Procedure' (AGP), and increases risks to staff who and complicates the cleaning and processing of rooms and equipment where AGPs are performed. Additionally, there is a severe limitation in availability of negative pressure rooms, which mitigate these AGPs.
With the COVID pandemic causing supply chain problems across the country, a multidisciplinary approach was required to appropriately ration available inhalers (MDI), the alternatives to nebulized treatments, while still treating patients who arrive with the need for these medications while maintaining maximal safety to staff.
Comments
Presented at the 2020 House Staff Quality Improvement and Patient Safety Conference